Nystatin and Aphthous stomatitis - a phase IV clinical study of FDA data

Summary:

Aphthous stomatitis is reported as a side effect among people who take Nystatin (nystatin), especially for people who are female, 60+ old, also take Dexamethasone, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Aphthous stomatitis when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.

What is Aphthous stomatitis?

Aphthous stomatitis (mouth ulcer) is found to be associated with 433 drugs and 811 conditions by eHealthMe. Check the latest studies of Aphthous stomatitis.

On Jul, 04, 2026

33,189 people reported to have side effects when taking Nystatin.
Among them, 51 people (0.15%) have Aphthous stomatitis.

Could Nystatin cause Aphthous stomatitis?

Among these 51 people:

What is the gender of people who have Aphthous stomatitis when taking Nystatin? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Aphthous stomatitis when taking Nystatin? *

What are other drugs people take besides Nystatin? *

Zometa: 23 people, 45.10%
Metronidazole: 23 people, 45.10%
Fluconazole: 23 people, 45.10%
Dexamethasone: 23 people, 45.10%
Chlorhexidine Gluconate: 22 people, 43.14%
Levaquin: 19 people, 37.25%
Aspirin: 19 people, 37.25%
Cymbalta: 19 people, 37.25%
Lortab: 17 people, 33.33%
Morphine: 17 people, 33.33%

What are other side effects people have besides Aphthous stomatitis? *

Back Pain: 28 people, 54.90%
Pain: 26 people, 50.98%
Stress And Anxiety: 25 people, 49.02%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 24 people, 47.06%
Dyspnea (difficult or laboured breathing): 24 people, 47.06%
Spondylolisthesis (displacement of a vertebra or the vertebral column in relation to the vertebrae below): 23 people, 45.10%
Swelling: 23 people, 45.10%
Intervertebral Disc Degeneration (spinal disc degeneration): 23 people, 45.10%
Oral Pain: 23 people, 45.10%
Fatigue (feeling of tiredness): 22 people, 43.14%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 19.61%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 10 people, 19.61%
Pain: 8 people, 15.69%
Metastases To Spine (cancer spreads to spine): 5 people, 9.80%
Hypersensitivity: 2 people, 3.92%
Swelling: 2 people, 3.92%
Abdominal Pain: 2 people, 3.92%
Renal Cell Carcinoma (a kidney cancer): 2 people, 3.92%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 3.92%
Pneumocystis Jiroveci Infection (fungal infection of the lungs): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Aphthous stomatitis?

- Check whether Aphthous stomatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystatin:

Nystatin (33,567 reports)

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aphthous stomatitis:

Aphthous stomatitis (433 drugs)

Browse all the conditions that are associated with Aphthous stomatitis:

Aphthous stomatitis (811 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.